NCT06916702View on ClinicalTrials.gov

A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 7, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Healthy
Interventions
DRUG

BI 3031185

BI 3031185

DRUG

Midazolam

Midazolam

DRUG

Placebo

Placebo matching BI 3031185

Trial Locations (1)

10117

RECRUITING

Charité Research Organisation GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06916702 - A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men | Biotech Hunter | Biotech Hunter